Navigation Links
Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
Date:8/11/2011

dvancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

About NUEDEXTA

NUEDEXTA® is the first and only FDA-approved treatment for pseudobulbar affect (PBA). NUEDEXTA is an innovative combination of two well-characterized components; dextromethorphan hydrobromide (20 mg), the ingredient active in the central nervous system, and quinidine sulfate (10 mg), a metabolic inhibitor enabling therapeutic dextromethorphan concentrations. NUEDEXTA acts on sigma-1 and NMDA receptors in the brain, although the mechanism by which NUEDEXTA exerts therapeutic effects in patients with PBA is unknown.

NUEDEXTA is indicated for the treatment of pseudobulbar affect (PBA). PBA occurs secondary to a variety of otherwise unrelated neurological conditions, and is characterized by involuntary, sudden, and frequent episodes of laughing and/or crying. PBA episodes typically occur out of proportion or incongruent to the patient's underlying emotional state. Studies to support the effectiveness of NUEDEXTA were performed in patients with amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). NUEDEXTA has not been shown to be safe and effective in other types of emotional lability that can commonly occur, for example, in Alzheimer's disease and other dementias. The primary outcome measure, laughing and crying episodes, was significantly lower in the NUEDEXTA arm compared to placebo. The secondary outcome measure, the Center for Neurologic Studies Lability Scale (CNS-LS), demonstrated a significantly greater mean decrease in CNS-LS score from baseline for the NUEDEXTA arm compared to placebo.

NUEDEXTA Important Safety Information

NUEDEXTA can interact with other medications causing significant changes in blood levels of those medications and/or NUEDEXTA. NUEDEXTA is contraindicated in patients rec
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
2. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
4. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
5. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
6. AVANIR Pharmaceuticals Announces NASDAQ Opening Bell Ceremony
7. AVANIR Pharmaceuticals Invites Investors to Fiscal 2011 First Quarter Conference Call
8. AVANIR Pharmaceuticals Announces Fiscal 2011 First Quarter Financial Results
9. AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
10. Avanir Pharmaceuticals to Present at Three Conferences in March
11. Avanir Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 Most osteoporosis patients want a choice in ... survey* sponsored by Mission Pharmacal Company. The survey, conducted ... online support community, revealed that 74 percent of osteoporosis ... a form other than a pill or a tablet. ...
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
(Date:1/15/2014)... 15, 2014 Massachusetts General Hospital (MGH), the ... ) announced today that they have launched a ... therapeutic targets and develop novel therapies for inflammatory ... millions worldwide. The MGH-Broad-Amgen collaboration brings together scientists ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4
... Encouraging Response in CF Patients - Results Validate ... March 27 The Cystic Fibrosis Foundation,announced today that ... defect in CF, showed promising results in an ongoing ... mutation of CF. The drug is,being developed by Vertex ...
... Research Associates, LLC,announced today that it has issued ... Inc. (TSX: BNC). The full 68-page report,can be ... a Canadian biopharmaceutical company that is committed to,improving ... animals worldwide through,innovative research, novel technologies, and therapeutics. ...
Cached Medicine Technology:Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 2Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 3Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc. 3
(Date:7/11/2014)... Anterior Cruciate Ligament (ACL) reconstructions occur more ... material used to create a new ligament may determine ... presenting their work today at the Annual Meeting of ... ). , “Our study results highlight that ... a donor) fail more frequently than using autografts (tissue ...
(Date:7/11/2014)... Re-tearing a repaired knee Anterior Cruciate Ligament (ACL) ... presented today at the American Orthopaedic Society for Sports ... education regarding modifiable risk factors may minimize the chance ... suggests that a few risk factors such as, age, ... to the possibility of re-injury," said lead author, Christopher ...
(Date:7/11/2014)... 11, 2014 With the maturity and ... on comfort, the installation rate of Chinese car electric ... installation rate exceeded 88% and the demand outnumbered 75 ... next few years, Chinese car electric window regulator market ... the market size is expected to exceed 110 million ...
(Date:7/11/2014)... 2014 Wild by Nature, a natural and ... they are opening a fifth store to be located in ... one of the largest selections of wheat and gluten-free products ... disease, these stores have become a one-stop shop for anyone ... sensitivity, and gluten intolerance, is a spectrum of disorders, including ...
(Date:7/11/2014)... July 11, 2014 B. E. Smith, the ... has been retained to lead a national chief nursing ... in Bend, Ore. The top executive search firm ... more than 900 healthcare executives into organizations. , With ... Charles Health System is the largest provider of medical care ...
Breaking Medicine News(10 mins):Health News:ACL Reconstructions May Last Longer With Autografts 2Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 2Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 3Health News:China Car Electric Window Regulator Industry to Grow at CAGR of 10% to 2017 Says a New Research Report at ChinaMarketResearchReports.com 4Health News:Wild by Nature Opens New Location 2Health News:St. Charles Health System Retains B. E. Smith to Recruit New CNO 2Health News:St. Charles Health System Retains B. E. Smith to Recruit New CNO 3
... Million Grant to Support In-depth, Explanatory Reporting , ... time of uncertainty and transition in the news media, the ... a unique partnership with the California HealthCare Foundation (CHCF) to ... , , Funded by a three-year ...
... , , Practice Abuses ... Group , , WASHINGTON, Sept. 17 ... the bureaucratic abuse of insured patients by for-profit insurance companies, Consumer ... about their use of employees to lobby Congress on company time. ...
... Obama ,plan, as transparent as a Cheney cabinet meeting, says Norquist ... spoke at length about what he called "my plan" before a joint session of Congress. ... several days. By our count he has mentioned the "plan": , , ... of Congress on Sept. 9 , 6 ...
... , , , ... Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare ... Med,s Chairman and CEO, will make a major new product announcement ... will be held at The Embassy Suites Boca Raton Hotel, Boca ...
... , Award recognizes local initiatives that ... CHICAGO, Sept. 17 YMCA of the USA today announced ... Casey Foundation FAMILIES COUNT Family Strengthening Award in recognition of their exemplary ... , This is the fourth year that YMCA of the ...
... , DALLAS, Sept. 17 Prostate cancer is the ... in six men being diagnosed with the disease in their lifetime. ... as a strong advocate for prostate cancer awareness, Kimberly-Clark and its ... End Prostate Cancer to help educate men on the risks associated ...
Cached Medicine News:Health News:USC Annenberg and California HealthCare Foundation Join in New Health Care Journalism Venture 2Health News:USC Annenberg and California HealthCare Foundation Join in New Health Care Journalism Venture 3Health News:Consumer Watchdog Says Insurers Must Answer Questions About Use of Employees as Mini-Lobbyists in Congress 2Health News:Where is President Obama's Health Care 'Plan'? 2Health News:Global Med Technologies, Inc.'s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wednesday, September 23, 2009 2Health News:Global Med Technologies, Inc.'s CEO to Make Major New Product Announcement the Morning of the LDV Investor Conference and Will Demo the Product on Wednesday, September 23, 2009 3Health News:YMCA of the USA and Annie E. Casey Foundation Honor Five YMCAs for Family Strengthening Excellence 2Health News:YMCA of the USA and Annie E. Casey Foundation Honor Five YMCAs for Family Strengthening Excellence 3Health News:YMCA of the USA and Annie E. Casey Foundation Honor Five YMCAs for Family Strengthening Excellence 4Health News:YMCA of the USA and Annie E. Casey Foundation Honor Five YMCAs for Family Strengthening Excellence 5Health News:Video: 'The Depend Campaign to End Prostate Cancer' Brings Sports Legends Together to Celebrate National Prostate Cancer Awareness Month 2
... Plate is a semi-rigid system intended ... The Slim-LOC is based on the ... current market technology. The Slim-LOCTM system ... instrumentation. Reduced width (16 mm), low ...
... SC-Acufix anterior cervical plate system is a ... integrated swivel, which provides for consistent, reliable ... bone screw disengagement or backout. This innovative ... locking screw. Simply implant your screws and ...
... a leading provider of telemedicine solutions. ... state-of-the-art technology deliver accurate, reliable and ... professionals and clients in improving outcomes. ... ECG technology to gather patient data, ...
... is a high performance temperature controlled shaker ... shaking speed and incubation time are fully ... parameters are displayed on the LCD in ... below the microplates provide uniform incubation with ...
Medicine Products: